Furthermore, recent systematic evaluations (ESC Guidelines, 2023) continue to affirm their clinical utility, highlighting NT-proBNP’s superiority due to its central role as a biomarker for guiding therapy and monitoring treatment efficacy of post-acute HF of HFpEF and HFmrEF subtypes [13]. Here, NPPB is linked to hydrops fetalis.